What are the recommended first‑line medication and psychotherapy options for treating anxiety?

First-Line Treatment for Anxiety Disorders

For adults with anxiety disorders, selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacotherapy, and cognitive behavioral therapy (CBT) is the recommended first-line psychotherapy. 1, 2

Pharmacotherapy Recommendations

First-Line Medications

SSRIs are the primary pharmacological choice for anxiety disorders, with specific agents including escitalopram, sertraline, paroxetine, and fluvoxamine showing efficacy across multiple anxiety disorder subtypes. 1, 2

• Venlafaxine (SNRI) is also recommended as a first-line option with comparable efficacy to SSRIs. 1
• The evidence base includes 26 randomized controlled trials for SSRIs and 5 for SNRIs, demonstrating treatment response rates of 60-85%. 1, 3
• International guidelines (NICE, German S3, Canadian CPG) consistently prioritize escitalopram and sertraline as first-line agents due to favorable side effect profiles and lower discontinuation symptoms compared to other SSRIs. 1

Medication Selection Algorithm

Start with escitalopram or sertraline as they have the strongest evidence for efficacy and tolerability. 1

• If inadequate response after adequate trial (typically 8-12 weeks at therapeutic dose), switch to another SSRI or venlafaxine. 1
• Paroxetine and fluvoxamine are equally effective but considered second-line due to higher rates of discontinuation symptoms and side effects. 1
• Continue medications for 6-12 months after remission to prevent relapse. 4, 5

Medications to Avoid

Benzodiazepines are NOT recommended for routine use due to addiction potential and lack of long-term efficacy data. 4, 5, 6

• Beta-blockers (atenolol, propranolol), antipsychotics (quetiapine), and tricyclic antidepressants (imipramine) are not recommended based on negative evidence. 1

Psychotherapy Recommendations

First-Line Psychotherapy

Cognitive behavioral therapy specifically developed for anxiety disorders is the recommended psychotherapy, delivered through individual sessions by a skilled therapist. 1, 2

• Individual CBT is prioritized over group therapy due to superior clinical and cost-effectiveness outcomes. 1
• Treatment should consist of approximately 14 sessions over 4 months, with each session lasting 60-90 minutes. 1
• Specific evidence-based models include the Clark and Wells model or Heimberg model for social anxiety disorder. 1

CBT Components

Effective CBT protocols must include:

• Psychoeducation on anxiety mechanisms 1
• Cognitive restructuring to modify maladaptive thought patterns 1
• Gradual exposure to feared situations (in vivo and imaginal) 1
• Behavioral experiments to test anxious predictions 1

Alternative Psychotherapy Options

If patients decline face-to-face CBT, self-help with support based on CBT principles is suggested as a second-line option. 1

Treatment Selection Strategy

For Mild to Moderate Anxiety

CBT should be considered the first-line treatment for patients with mild to moderate anxiety presentations. 7

• CBT has comparable efficacy to medications without pharmacological side effects. 7, 2
• This approach is particularly appropriate when quality CBT is accessible. 7

For Moderate to Severe Anxiety

SSRIs or SNRIs are appropriate first-line treatments for more severe presentations or when CBT is unavailable. 7, 3

• Pharmacotherapy provides more rapid symptom relief in severe cases. 7
• Medication is available at any psychiatric facility and is cost-effective. 1

Combination Therapy

There is insufficient evidence to routinely recommend combining pharmacotherapy and psychotherapy over monotherapy for anxiety disorders. 1

• However, for children and adolescents, combination treatment (CBT plus SSRI) may be more effective than either treatment alone. 7
• The evidence for adults remains equivocal, and the guideline makes no recommendation for or against combination therapy. 1

Pediatric Considerations

For children and adolescents with anxiety disorders, CBT is the preferred first-line treatment, particularly for mild to moderate presentations. 7

• SSRIs are an alternative consideration for more severe presentations or when quality CBT is unavailable. 7
• SNRIs have some empirical support as an additional treatment option in pediatric populations. 7
• Combination treatment (CBT plus SSRI) may be more effective than either treatment alone in youth. 7

Common Pitfalls to Avoid

Do not prescribe benzodiazepines as first-line treatment despite their rapid anxiolytic effects, as they carry addiction risk and lack evidence for long-term efficacy. 4, 5

Do not discontinue medications abruptly after symptom remission; continue for 6-12 months and taper slowly when discontinuing to prevent relapse. 4, 5, 8

Do not use non-evidence-based psychotherapies as first-line treatment when CBT is available and appropriate. 1

Ensure CBT is delivered by skilled therapists following structured protocols rather than generic supportive counseling, as treatment fidelity significantly impacts outcomes. 1

Monitoring Requirements

Treatment monitoring should be performed by a physician with expertise in anxiety disorder diagnosis and treatment. 1

• Assess treatment response at 4-6 weeks and adjust dosing or switch medications if inadequate response. 1
• Monitor for treatment-emergent side effects, particularly activation symptoms in the first 2 weeks of SSRI/SNRI treatment. 7
• Evaluate functional improvement in social, occupational, and interpersonal domains, not just symptom reduction. 1